Targeting VEGF, EGFR, and Other Interacting Pathways for Gastric Cancer—Promises and Reality

Author： Liakakos T.  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.15, Iss.10, 2008-10, pp. : 2981-2982

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo

By          

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1687-1692

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C

By Li Guangyan   Yang Fang   Gu Shiyu   Li Zhenjuan   Xue Minghui  

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 572-578

Spandidos Publications

Access to resources Recommend Favorite

Targeting Cancer Stem Cells: Promises and Challenges

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 1, 2016-01 ,pp. : 38-58

Bentham Science Publishers

Access to resources Recommend Favorite

The landscape of EGFR pathways and personalized management of non-small-cell lung cancer

By Cheng Liang   Zhang Shaobo   Alexander Riley   Yao Yongxue   MacLennan Gregory T   Pan Chong-xian   Huang Jiaoti   Wang Mingsheng   Montironi Rodolfo   Lopez-Beltran Antonio  

Future Oncology, Vol. 7, Iss. 4, 2011-04 ,pp. : 519-541

Future Medicine

Access to resources Recommend Favorite

Targeting HER1/EGFR in cancer therapy: experience with erlotinib

By Giaccone Giuseppe  

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 449-460

Future Medicine

Access to resources Recommend Favorite